Home > News > Interim Report Obducat
April 29th, 2004
Interim Report Obducat
Abstract:
Directed new share issue in January 2004 contributed some SEK 13 million, Turnover SEK 4,4 (9,0) million - forecast sales growth of 25-30 per cent in 2004 remains, Obducat partner in EU sponsored nano project NaPa, Pre-tax profit was SEK –9,5 million (–7,9) and earnings per share before deferred dilution was SEK –0,05 (-0,05). (PDF)
Source:
Obducat
Bookmark:
Financial Reports
Nanobiotix Revenue for the 1st quarter of 2013 May 15th, 2013
Harris & Harris Group Reports Financial Statements as of March 31, 2013 May 10th, 2013
Arrowhead Reports Fiscal 2013 Second Quarter Financial Results - Conference Call Today at 4:30 p.m. Eastern Time May 9th, 2013
Arrowhead to Report Fiscal 2013 Second Quarter Financial Results - Conference Call Scheduled for Thursday, May 9, 2013 May 2nd, 2013